Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 7612114 Selective estrogen receptor modulator

Patent 7612114 was granted and assigned to Eisai on November, 2009 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Current Assignee

0

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

Atsushi Sasaki0

Noritaka Kitazawa0

Shinichi Hamaoka0

Tadashi Okabe0

Kazumasa Nara0

Atsushi Kamada0

Date of Patent

November 3, 2009

0

Patent Application Number

111582450

Date Filed

June 22, 2005

0

Patent Citations Received

US Patent 12024522 Salts and processes of preparing a PI3K inhibitor

0

US Patent 11676731 Diagnostic and therapeutic methods for the treatment of breast cancer

0

US Patent 11708318 Polymorphic forms of RAD1901-2HCL

0

US Patent 11713296 Salts of methyl 6-(2,4-dichlorophenyl)-5-[4-[(3S)-l-(3-fluoropropyl)pyrrolidin-3-yl]oxyphenyl]-8,9-dihydro-7H-benzo[7]annulene-2-carboxylate and preparation process thereof

0

US Patent 11771682 AR+ breast cancer treatment methods

US Patent 11779552 Method of treating cancer using selective estrogen receptor modulators

US Patent 11819505 Heterocyclylamines as PI3K inhibitors

0

US Patent 11857518 Methods for treating cancer

0

...

Patent Primary Examiner

Charanjit S. Aulakh

0

Patent abstract

The present invention provides a compound represented by the following formula (I);

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 7612114 Selective estrogen receptor modulator

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.